Papillary renal cell carcinoma: Analysis of germline mutations in the MET proto-oncogene in a clinic-based population

Genetic Testing

Volumn 5, Issue 2, 2001, Pages 101-106

  Lindor, N M ^a   Dechet, C B ^a   Greene, M H ^b   Jenkins, R B ^a   Zincke, M T ^a   Weaver, A L ^a   Wilson, M ^a   Zincke, H ^a   Liu, W ^a  

^a MAYO CLINIC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME 7; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY CARCINOMA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PROTO ONCOGENE; RETROSPECTIVE STUDY; TREATMENT INDICATION;

EID: 0034869788     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065701753145547     Document Type: Article

References (31)

1. Papillary (chromophil) renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases
2. A highly sensitive, fast and economical technique for mutation analysis in hereditary breast and ovarian cancers
3. Familial colorectal cancer. Diagnosis and management
4. Overexpression and amplification of the MET/HGF receptor gene during the progression of colorectal cancer
5. The genetics of breast and ovarian cancer
6. Mutations in the VHL tumor suppressor gene in renal cell carcinoma
7. Hapatocyte growth factor/scatter factor-MET signaling in tumorigenicity and invasion/metastasis
8. Molecular differential pathology of renal cell tumours
9. The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours
10. Cytogenetics of papillary renal cell tumors
11. Development of papillary renal cell tumours is associated with loss of Y-chromosome-specific DNA sequences
12. The concise handbook of family cancer syndromes
13. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas
14. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations
15. Papillary renal cell carcinoma. A clinical, radiologic and pathologic study of 34 cases
16. Translocation (X:1) in papillary renal cell carcinoma. A new cytogenetic subtype
17. Analysis of papillary renal adenocarcinoma
18. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca(2+) channel gene CACNL1A4
19. Somatic mutations in the kinase domain of the MET/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas
20. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
21. Two North American families with hereditary papillary renal cell carcinoma and identical novel mutations in the MET proto-oncogene
22. Novel mutations of the MET proto-oncogene in papillary renal carcinomas
23. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene
24. A pre-Columbian Y chromosome-specific transition and its implications for human evolutionary history
25. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas
26. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer
27. PTEN/MMAC1 mutations identified in small cell but not in non-small cell lung cancers
28. Hereditary papillary renal cell carcinoma
29. Hereditary papillary renal cell carcinoma: Clinical studies in 10 families
30. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas